Cardiomyopathy Trial, Recruiting (NCT06034405)

Cardiomyopathy Trial, Recruiting NCT06034405 Sponsor: Columbia University Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06034405 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had spinal decompression surgery (a procedure to relieve pressure on the spine or nerves) within the past 20 years before joining the study.
People who were aged 50 or older at the time of that spinal surgery.
People who are able to understand and sign a consent form after the study has been fully explained to them.

Who may not be able to join:

People who have been diagnosed with a specific type of protein build-up disorder called primary amyloidosis (AL) or secondary amyloidosis (AA).
People who have a known diagnosis of TTR amyloidosis (a condition where a particular protein called transthyretin builds up abnormally in the body).
People who have any other condition or circumstance that the trial team considers would make participation unsuitable (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mathew S Maurer, MD, Columbia University

Phone: 212-932-4537

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06034405

Sponsor: Columbia University

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 212-932-4537

More information: https://clinicaltrials.gov/study/NCT06034405

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had spinal decompression surgery (a procedure to relieve pressure on the spine or nerves) within the past 20 years before joining the study.
People who were aged 50 or older at the time of that spinal surgery.
People who are able to understand and sign a consent form after the study has been fully explained to them.

Who may not be able to join:

People who have been diagnosed with a specific type of protein build-up disorder called primary amyloidosis (AL) or secondary amyloidosis (AA).
People who have a known diagnosis of TTR amyloidosis (a condition where a particular protein called transthyretin builds up abnormally in the body).
People who have any other condition or circumstance that the trial team considers would make participation unsuitable (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Columbia University

Registry

ClinicalTrials.gov

Start date

19 September 2023

Est. completion

1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percent of subjects with previous LSS surgery who have evidence of TTR amyloid deposits in their spinal specimen and could be at risk for ATTR cardiac amyloidosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov